The bacterial ubiD and ubiX or the homologous fungal fdc1 and pad1 genes have been implicated in the non-oxidative reversible decarboxylation of aromatic substrates, and play a pivotal role in bacterial ubiquinone (also known as coenzyme Q) biosynthesis [1] [2] [3] or microbial biodegradation of aromatic compounds 4-6 , respectively. Despite biochemical studies on individual gene products, the composition and cofactor requirement of the enzyme responsible for in vivo decarboxylase activity remained unclear 7-9 . Here we show that Fdc1 is solely responsible for the reversible decarboxylase activity, and that it requires a new type of cofactor: a prenylated flavin synthesized by the associated UbiX/Pad1 10 . Atomic resolution crystal structures reveal that two distinct isomers of the oxidized cofactor can be observed, an isoalloxazine N5-iminium adduct and a N5 secondary ketimine species with markedly altered ring structure, both having azomethine ylide character. Substrate binding positions the dipolarophile enoic acid group directly above the azomethine ylide group. The structure of a covalent inhibitor-cofactor adduct suggests that 1,3-dipolar cycloaddition chemistry supports reversible decarboxylation in these enzymes. Although 1,3-dipolar cycloaddition is commonly used in organic chemistry 11,12 , we propose that this presents the first example, to our knowledge, of an enzymatic 1,3-dipolar cycloaddition reaction. Our model for Fdc1/UbiD catalysis offers new routes in alkene hydrocarbon production or aryl (de)carboxylation.
The bacterial ubiD and ubiX or the homologous fungal fdc1 and pad1 genes have been implicated in the non-oxidative reversible decarboxylation of aromatic substrates, and play a pivotal role in bacterial ubiquinone (also known as coenzyme Q) biosynthesis [1] [2] [3] or microbial biodegradation of aromatic compounds [4] [5] [6] , respectively. Despite biochemical studies on individual gene products, the composition and cofactor requirement of the enzyme responsible for in vivo decarboxylase activity remained unclear [7] [8] [9] . Here we show that Fdc1 is solely responsible for the reversible decarboxylase activity, and that it requires a new type of cofactor: a prenylated flavin synthesized by the associated UbiX/Pad1 10 . Atomic resolution crystal structures reveal that two distinct isomers of the oxidized cofactor can be observed, an isoalloxazine N5-iminium adduct and a N5 secondary ketimine species with markedly altered ring structure, both having azomethine ylide character. Substrate binding positions the dipolarophile enoic acid group directly above the azomethine ylide group. The structure of a covalent inhibitor-cofactor adduct suggests that 1,3-dipolar cycloaddition chemistry supports reversible decarboxylation in these enzymes. Although 1,3-dipolar cycloaddition is commonly used in organic chemistry 11, 12 , we propose that this presents the first example, to our knowledge, of an enzymatic 1,3-dipolar cycloaddition reaction. Our model for Fdc1/UbiD catalysis offers new routes in alkene hydrocarbon production or aryl (de)carboxylation.
Decarboxylation is among one of the most common reactions in nature, despite the fact it is inherently difficult to achieve at ambient conditions. This is due to the high energy of the carbanion intermediate that is formed concomitant with carbon dioxide formation. To overcome this challenge, the majority of decarboxylases 13 make use of cofactors, including organic cofactors such as flavins, pyridoxal phosphate (PLP), thiamine pyrophosphate (TPP) or metal ions such as Mg 21 , Fe 21 or Mn 21 . Decarboxylation is also frequently coupled to substrate oxidation. Comparatively few decarboxylases have been shown to require no cofactor and in these selected cases catalysis involves non-oxidative decarboxylation of those substrates for which the corresponding carbanion species can be stabilized using simple acid-base chemistry. Examples include orotidine monophosphate decarboxylase 14 and arylmalonate decarboxylase 15 .
The ubiX and ubiD or the related pad1 and fdc1 genes have been shown to be responsible for non-oxidative reversible decarboxylation of aromatic substrates [1] [2] [3] [4] [5] [6] (Fig. 1a ). These genes are widely distributed in archaeal, bacterial and fungal genomes 16 , and ubiX and ubiD feature in the prokaryotic ubiquinone biosynthetic pathway [1] [2] [3] . Genetic studies have led to the suggestion that both genes encode (redundant) decarboxylases 17 . However, although UbiX/Pad1 proteins are distantly related to flavin-containing cysteine decarboxylases and have been shown to bind FMN, no in vitro decarboxylase activity has been detected 7, 18 . Furthermore, most biochemical studies of UbiD/Fdc1 have also failed to detect in vitro activity 8, 19 . Although recent UbiD/Fdc1 structures reveal distant structural homology to a family of NADH-FMN oxidoreductases, only metal ion binding rather than flavin binding has been reported 8 . Hence, the composition and putative cofactor requirement of the enzyme responsible for the observed in vivo decarboxylase activity remained unclear.
We co-expressed the Aspergillus niger fdc1 gene in E. coli with either the associated A. niger pad1 or the homologous ubiX from E. coli. Although no direct interaction could be detected between the purified Fdc1 and either UbiX or Pad1 proteins, clear differences could be observed between single expressed Fdc1 and the corresponding ubiX or pad1 co-expressed Fdc1 protein (denoted Fdc1 UbiX ). Purified Fdc1 UbiX has distinct spectral properties ( Fig. 1b ) and catalyses reversible decarboxylation of a wide range of aromatic carboxylic acids in vitro (Fig. 1c, d and Extended Data Fig. 1 ). Similar observations were made for Saccharomyces cerevisiae Fdc1 UbiX , although in this case the corresponding Fdc1 singly expressed protein (but not Fdc1 UbiX ) weakly binds FMN (Extended Data Fig. 2 ). During the review stage for this publication, similar observations for the S. cerevisiae Fdc1 were reported elsewhere, although the Fdc1 cofactor was not identified 20 .
Crystal structures of A. niger, Candida dubliniensis and S. cerevisiae Fdc1 UbiX reveal a heavily modified FMN cofactor is bound by these enzymes (Fig. 2 and Extended Data Fig. 3 ). The modified FMN phosphate is bound in complex with metal ions, similar to the distantly related FMN-binding protein from Methanobacterium thermoautotrophicum 21 . The electron density suggests both Mn 21 and K 1 ions are present, and Mn 21 binding can be detected using EPR (Extended Data Fig. 4 ). Early studies on E. coli UbiD revealed activation by both Mn 21 and an unidentified cofactor 3 . The electron density for the modified FMN reveals extensive modification has occurred at both N5 and C6 positions, effectively adding a fourth ring to the isoalloxazine moiety (Fig. 2b) . The atomic resolution obtained for A. niger Fdc1 UbiX allows identification of the cofactor structure as an isopentenyl-adduct to the flavin N5-C6 or prenylated FMN (prFMN) (Fig. 2c ). The branched nature of the isopentenyl adduct and the position of the covalent linkages with the flavin suggest this modification is achieved through prenylation. In the accompanying paper 10 , we show that UbiX indeed acts as a flavin prenylase enzyme that can support Fdc1 activation in vitro. Activation is dependent on the presence of oxygen, suggesting the reduced prFMN UbiX product is oxidized to the corresponding flavo-N5 iminium adduct (prFMN iminium ; Fig. 2d ). The presence of the oxidized prFMN was confirmed by high-resolution mass spectrometry of both the isolated cofactor and native mass spectrometry of the Fdc1 UbiX protein (Extended Data Fig. 5 ). Furthermore, complete inactivation of Fdc1 UbiX was achieved using the mild reductant sodium cyanoborohydride. Upon reoxidation of the sodium cyanoborohydride inactivated enzyme, a radical species was formed with spectral and EPR properties similar to that of the prFMN? radical species detected during non-physiological oxidation of the UbiX-prFMN complex 10 ( Fig. 2e and Extended Data Fig. 4 ).
Furthermore, the amount of prFMN? radical formed is proportional to the levels of enzyme activity obtained before cyanoborohydride inactivation ( Fig. 2f ), suggesting that enzyme inactivation occurs by modification (probably hydrolysis) of the active prFMN species.
Marked heterogeneity of the prFMN ox cofactor is observed in the A. niger Fdc1 UbiX wild-type crystal structures, with older crystal samples revealing an increased population of a hydroxylated prFMN iminium . The latter species could also be observed by highresolution mass spectrometry (Extended Data Fig. 5a) . Surprisingly, a distinct prFMN ox isomer (prFMN ketimine ) can be observed for most A. niger Fdc1 crystals, although it is not detected in the C. dubliniensis or S. cerevisiae crystals (Fig. 3a ). This form contains an altered isoalloxazine ring structure, a likely consequence of isomerization of the extended ring system during oxidative maturation of the prFMN cofactor. We propose this isomerization step occurs during the stepwise oxidation of the reduced prFMN UbiX product, via a radical mechanism (Extended Data Fig. 6 ). The isomerization leads to insertion of the prenyl C19 carbon into the flavin isoalloxazine ring, creating a central seven-membered ring and converting the N5-iminium into a secondary ketimine. The conformation derived from density functional theory (DFT) calculations for the proposed prFMN ketimine species is in close agreement with that observed in the crystal structure. The calculations indicate this species is 30-40 kJ mol 21 lower in gas phase free energy than the prFMN iminium species and can exist in two butterfly bent-like conformations of similar energy (Extended Data Fig. 7) .
To obtain insights into the catalytic mechanism, A. niger Key residues involved in polar interactions with the isoalloxazine derived cofactor moiety are shown as sticks. d, Chemical structure of the modified FMN bound by A. niger Fdc1 UbiX as derived from atomic resolution density and high-resolution mass spectrometry (Extended Data Fig. 5 ). Atoms derived from dimethylallyl-monophosphate are shown in red 10 . The azomethine ylide resonance form is shown below. e, Oxidation of cyanoborohydride inactivated Fdc1 UbiX leads to formation of a purple species, similar in UV-visible and EPR spectral properties (Extended Data Fig. 4 ) to that observed for the oxidized UbiX-prFMN complex 10 . f, Following purification, Fdc1 UbiX activity gradually decreases when incubated on ice, and formation of the purple prFMN radical following NaBH 3 CN treatment follows a similar trend (error bars are s.d., n 5 3).
reveal substrates are stacked directly above the prFMN ox ring system (Fig. 3b , c). Electron density for both the iminium and ketimine species can be detected in the atomic resolution density maps, the latter adopting a more planar conformation of the extended ring system in order to accommodate substrate binding (Fig. 3b , c and Extended Data Fig. 7 ). The substrate enoic acid double bond is positioned directly above the C4a of both the prFMN ox species. Although the aryl-group of all substrates tested occupies a similar position directly above the prFMN N1 atom, electron density corresponding to the carboxylate moiety is distinct for each substrate (Fig. 3c ). Although clear electron density for the pentafluorocinnamic acid carboxylate is lacking, both a-methylcinnamic acid and a-fluorocinnamic acid carboxylate groups can be observed. Both occupy a position vacated by reorientation of the conserved E282, and establish polar contacts with R173 and the amide nitrogen of M283. In the case of a-methylcinnamic acid, the carboxylate is within hydrogen bonding distance of the N5 secondary ketimine group of the prFMN ketimine form. A complex with the decarboxylation product 4-vinyl guaiacol (a distinct flavouring agent obtained by yeast-mediated decarboxylation of ferulic acid) reveals a similar position for the aryl-moiety (Fig. 3c ). The vinyl group is placed directly above the prFMN ox C4a, in close proximity to electron density resembling a bound CO 2 molecule. At first glance, the position of the substrate a,b-unsaturated carbonyl directly above the prFMN ox C4a suggests the possibility of transient formation of a prFMN ox C4a substrate b-carbon bond reminiscent of Michael addition-like chemistry and other flavin-catalysed reactions 22 . This mechanism has similarities to the amidohydrolasetype decarboxylases, where nucleophilic attack by a metal-bound hydroxide ion is postulated to lead to transient C5C bond cleavage of an enoic acid moiety leading to decarboxylation 13, 23 . In the case of Fdc1, C5C bond cleavage should proceed with concomitant protonation of the a-carbon to allow decarboxylation. Our structural data suggests the N5 secondary ketimine of prFMN ketimine could act as a probable acid-base catalyst, providing a rationale for both FMN modification and rearrangement ( Fig. 4a and Extended Data Fig. 7b ). However, although our solution mass spectrometry and chemical inhibition data cannot distinguish between the iminium and ketimine cofactor isomers, solution data presented in Fig. 2e , f suggests prFMN iminium is the catalytically relevant species.
To determine which prFMN ox isomer supports catalysis by Fdc1 UbiX and provide further insight into the likely mechanism, we sought to determine the structure of a covalent substrate-cofactor adduct. When A. niger Fdc1 UbiX protein is incubated with phenylpyruvate, for which the corresponding enol-tautomer a-hydroxycinnamic acid (present as a minor population in solution) closely resembles the cinnamic acid substrate, the UV-visible spectrum is altered (Fig. 4b ). Similar observations are made when incubating with phenylacetaldehyde. Furthermore, incubation with phenylpyruvate or phenylacetaldehyde leads to reversible enzyme inhibition, with a gradual increase of enzyme activity upon removal of excess phenylpyruvate (Fig. 4b) . The corresponding crystal structure of A. niger Fdc1 UbiX incubated with phenylpyruvate reveals a covalent adduct formed between the prenyl-C19 of the prFMN iminium cofactor and a substrate-derived entity (Fig. 4c ). Atomic resolution electron density reveals the latter clearly corresponds to a phenylacetaldehyde adduct, a species that can be formed following decarboxylation of a-hydroxycinnamic acid and tautomerisation of the corresponding a-hydroxystyrene prFMN iminium adduct ( Fig. 4d , species IIIb). The reversible inhibition observed can be accounted for by the fact the corresponding enol-keto tautomer equilibrium is in favour of the off-pathway phenylacetaldehyde adduct. This observation further confirms that prFMN iminium is the catalytically relevant species, and the unexpected presence of a C19-substrate a-carbon bond suggests a distinct mechanism from that of the amidohydrolase-type decarboxylases occurs ( Fig. 4d ). Fluorination of the substrate b-carbon or the aromatic group has only a modest effect on catalysis ( Fig. 1d ). Furthermore, simple enoic acids also act as substrates, as prolonged incubation of Fdc1 UbiX with these substrates does lead to formation of the corresponding terminal alkenes (a-olefins) at modest levels (Extended Data Fig. 8 ). Both observations argue against formation of transient ionic species.
The neutral form of the prFMN iminium has distinct azomethine ylide character (a well-known 1,3-dipole) that is positioned directly adjacent to the substrate a,b-unsaturated carbonyl (a dipolarophile) by the enzyme. Thus, we propose a 1,3-dipolar cycloaddition between the substrate and the prFMN iminium azomethine ylide form leads to a transient covalent substrate-prFMN iminium pyrrolidine adduct, establishing covalent bonds with both C19 and C4a (species II). Ample precedent is available for the concerted 1,3-dipolar cycloaddition between azomethine ylides and a,b-unsaturated carbonyls in organic chemistry 11, 12 . Whether the proposed Fdc1-mediated cycloaddition occurs through a single pericyclic transition state cannot be established at this stage. Fragmentative decarboxylation (Grob-type fragmentation 24 ) of the pyrrolidine adduct II can occur coupled to breaking the b-carbon-prFMN C4a bond. This leaves a single bond connecting the substrate a-carbon with the C19 of prFMN iminium (species IIIa), as observed in the phenylpyruvate adduct IIIb. We propose protonation by E282 concomitant with formation of a second pyrrolidine adduct (species V) leads to product formation (species VI) via a retro 1,3-dipolar cycloaddition. Together with R172 and E277, E282 forms a network of polar interactions that is conserved throughout the UbiD/Fdc1 family. The R173A, E277Q and E282Q variants of Fdc1 UbiX are all inactive, and display altered UV-visible spectrum properties, suggesting these mutations also affect cofactor maturation (Extended Data Fig. 9 ).
The modification of the flavin isoalloxazine ring through prenylation at N5 and C6, followed by oxidation strikingly alters and expands the flavin chemical repertoire 22 . Oxidation of the N5-prenyl adduct bond leads either to the corresponding iminium adduct or, when coupled to ring isomerization, a secondary ketimine adduct. Both species have azomethine ylide character and distinct catalytic 
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potential. In the Fdc1/UbiD enzyme family, the prFMN iminium form supports reversible decarboxylation of a wide range of (aromatic) substrates. Although the [312] reaction between azomethine ylide dipoles and alkene dipolarophiles has been extensively used in organic chemistry 11, 12 , the mechanism proposed here would present the first example, to our knowledge, of a biological [312] reaction. Combined with the recent description of both natural 25 and artificial 26 bona fide [412] cycloaddition catalysing enzymes, this hints at more widespread use of pericyclic reaction chemistry in nature. As Fdc1/UbiD enzymes have evolved from an NADH-FMN oxidoreductase module 8, 21 , the distinct possibility exists that other unrelated prFMN-dependent enzymes might have developed from distinct flavin-binding modules. Such distinct prFMN-dependent enzymes could make use of different aspects of the prFMN chemistry, as occurs with other organic cofactors 27 . Artificial flavoenzymes containing N5-alkylated flavins have been created that are capable of H 2 O 2 -driven enantioselective sulfoxidations 28 , using the fact that N5-alkylated flavins can form remarkably stable 4a-peroxyflavins and are powerful oxidising catalysts 29 . It is possible similar enzymes already exist in nature.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Cloning. The S. cerevisiae, C. dubliniensis and A. niger fdc1 genes were codon optimized and synthesized (Genscript). The A. niger fdc1 gene was cloned into the NdeI and XhoI sites of pET30a and the S. cerevisiae and C. dubliniensis genes were cloned into the NdeI and XhoI sites of pET21b. E. coli ubiX was cloned into the NdeI and XhoI sites of pET21b and pET30a. A. niger fdc1 pET30a was transformed into E. coli BL21(DE3) with and without ubiX pET21b and S. cerevisiae and C. dubliniensis fdc1 pET21b were transformed into E. coli BL21(DE3) with and without ubiX pET30a. Mutagenesis. Mutagenesis primers were designed using the QuikChange Primer Design Program (http://www.genomics.agilent.com/primerDesignProgram.jsp). PCR was performed using Phusion polymerase (NEB). Template was removed by DpnI (NEB) digestion and the PCR product transformed into E. coli NEB5a.
Once the presence of the desired mutation was confirmed by DNA sequencing, the plasmid was co-transformed with the appropriate ubiX construct into E. coli BL21(DE3). Protein expression and purification. Protein was expressed in BL21(DE3) grown at 37 uC at 180 r.p.m. in LB broth supplemented with 50 mg ml 21 kanamycin and/ or 50 mg ml 21 ampicillin. At mid-log phase cells were induced with 0.25 mM IPTG and supplemented with 1 mM MnCl 2, grown overnight at 15 uC at 180 r.p.m. and then collected by centrifugation (4 uC, 7,000g for 10 min). Cell pellets were resuspended in buffer A (200 mM NaCl, 1 mM MnCl 2 , 50 mM Tris pH 7.5) supplemented with DNase, RNase, lysozyme (Sigma) and Complete EDTA-free protease inhibitor cocktail (Roche). Cells were lysed using a French press at 20,000 p.s.i. and the lysate clarified by centrifugation at 125,000g for 90 min. The supernatant was applied to a Ni-NTA agarose column (Qiagen). The column washed with 3 column volumes of buffer A supplemented with 10 mM imidazole and protein eluted in 1-ml fractions with buffer A supplemented with 250 mM imidazole. Samples were subjected to SDS-PAGE analysis and fractions found to contain the purified protein were pooled. Imidazole was removed using a 10-DG desalting column (Bio-Rad) equilibrated with 100 mM NaCl, 1 mM MnCl 2 , 25 mM Tris pH 7.5.
Protein was aliquoted and flash frozen until required. UV-visible spectroscopy/protein quantification. UV-visible absorbance spectra were recorded with a Cary UV-vis spectrophotometer. The protein concentration of A. niger Fdc1 and S. cerevisiae Fdc1 was estimated using e 280 5 68,870 M 21 cm 21 and e 280 5 63,830 M 21 cm 21 (calculated from the primary amino acid sequence using the ProtParam program on the ExPASy proteomics server), respectively. UV-visible decarboxylation assays. For substrates with two or more double bonds conjugated to the acid group initial rates were determined by following consumption of substrate by UV-visible spectroscopy using a Cary 50 Bio spectrophotometer (Varian). Assays were performed against various concentrations of substrate in 350 ml 50 mM KCl, 50 mM NaPi pH 6 in a 1 mm path length cuvette at 25 uC. The rate of 2,3,4,5,6-penta-fluorocinnamic acid consumption was monitored at 260 nm, a-fluorocinnamic acid at 265 nm, cinnamic acid at 270 nm and sorbic acid at 260 nm. Extinction coefficients for each substrate were calculated from a range of standards and found to be e 260 5 20,000 M 21 cm 21 for 2,3,4,5,6penta-fluorocinnamic acid; e 265 5 20,000 M 21 cm 21 for a-fluorocinnamic acid; e 270 5 20,000 M 21 cm 21 for cinnamic acid; and e 260 5 24,000 M -1 cm 21 for sorbic acid, the latter two values being in good agreement with the literature 30, 31 .
A. niger Fdc1 phenylpyruvate inhibition. Sodium phenylpyruvate powder was added to the protein until there was no further change in the ,A 380 spectrum. Any precipitate was removed by centrifugation at 16,100g and excess phenylpyruvate in solution removed using a 10-DG desalting column (BioRad). A. niger Fdc1 inactivation timecourse. Enzyme was thawed and incubated on ice. The enzyme was assayed against cinnamic acid at various time points and the level of activity expressed as a percentage of that of freshly thawed protein (0 min). At various time points samples were also treated with NaBH 3 CN powder, centrifuged at 16,100g for 15 min and UV-visible spectra recorded. GC headspace decarboxylation assays. A total of 500 ml 10 mM substrate (2hexenoic acid, 2-heptenoic acid, 2-octenoic or 2-nonenoic acid), 50 mM KCl, 50 mM NaPi pH 6 in a 2 ml GC vial was incubated with or without enzyme at 25 uC with continuous shaking. 0.5 ml head space volume was manually drawn off, and injected into the GC with a syringe-lock needle. A Varian 3800 GC equipped with a DB-WAX column (30 m 3 0.32 mm 3 0.25 mm film thickness, JW Scientific) was used to detect and quantify 1-alkenes produced during the enzyme reactions. The column temperature was programmed as follows: 40 uC hold for 2 min, to 150 uC at 20 uC min 21 . The injector temperature was 250 uC (10:1 split), and the FID temperature was set at 250 uC. The carrier gas was helium at a flow rate of 1 ml min 21 . Product identification was achieved by comparison with pure 1-alkene standards. Carboxylation HPLC assays. Assays containing 10 mM styrene, 100 mM NaPi pH 6, 3 M NaHCO 3 (final pH 7.5), were incubated with and without enzyme at 25 uC overnight. The sample was centrifuged at 16,100g to remove precipitate and 100 ml added to 900 ml 50% v/v H 2 0/acetonitrile. Sample analysis was performed using an Agilent 1100 Series HPLC equipped with a UV detector. The stationary phase was a Kinetex 5 mm C18 100A column, 250 3 4.6 mm. The mobile phase was acetonitrile/water (50/50) with 0.1% TFA at a flow rate of 1 ml min 21 , and detection was performed at a wavelength of 254 nm. EPR. NaBH 3 CN powder was added to Fdc1 UbiX (215 mM). The samples were incubated on ice and UV-visible spectra recorded until the purple colour (A 550 ) reached a maximum. The samples were centrifuged to remove any remaining powder or effervescence, 300 ml of sample was transferred to an EPR tube and frozen in liquid nitrogen. EPR spectra were obtained using a Bruker ELEXSYS E500 EPR spectrometer equipped with a Super High Q (ER 4118-SHQ) resonator. Temperature control was achieved using an Oxford Instruments ESR900 cryostat connected to an ITC 503 temperature controller from the same manufacturer.
Protein crystallization and structure determination. Crystallization was performed by vapour diffusion. An initial screening of 0.3 ml 14 mg ml 21 A. niger All crystals were cryoprotected in mother liquor supplemented with 10% PEG 200 and flash cooled in liquid nitrogen. Diffraction data was collected at Diamond beamlines at 100K and processed using the CCP4 suite 32 . Data was reduced and scaled using XDS 33 . Following molecular replacement using 4IP2 as a starting model, the structures of wild-type A. niger and S. cerevisiae Fdc1 and complexes were refined using REFMAC5 (ref. 32) , and refined by cycles of manual rebuilding in COOT. Ligand coordinates and definitions were generated using the GlycoBioChem PRODRG2 server (http://davapc1.bioch.dundee.ac.uk/cgi-bin/ prodrg). The data and refinement statistics are available in Extended Data Table 1 . Native mass spectrometry. Protein was buffer exchanged into 100 mM ammonium acetate using a 10-DG desalting column (BioRad). Native mass spectrometry experiments were carried out on a Synapt G2 instrument (Waters, Manchester, UK) with a nanoelectrospray ionisation (nESI) source. Mass calibration was performed by a separate infusion of NaI cluster ions. Solutions were ionised through a positive potential applied to a platinum wire of thickness 0.125 mm (Goodfellow) inserted into a thin-walled glass capillary (inner diameter 0.9 mm, outer diameter 1.2 mm, World Precision Instruments, Stevenage, UK) that was pulled to a nESI tip in house with a Flaming/Brown micropipette puller (Sutter Instrument Co., Novato, CA). Fdc1 samples (5-10 mM) were sprayed from 100 mM ammonium acetate pH 6.8. Capillary voltage 1.6 kV, sample cone voltage 80-90 V, extractor cone voltage 3 V, backing pressure 5 mbar, source temperature 50 uC, trap gas flow 0.4-5 ml min 21 . Data were processed using Masslynx V4.1 software and Originlab 9.0. Mass spectrometry analysis of the extracted Fdc1 cofactor. Protein was buffer exchanged into deionised H 2 O using a 10-DG column. 4 ml 1 M ammonium acetate was added to 200 ml protein solution. The protein was precipitated and cofactor released with addition of 200 ml acetonitrile and incubation at 70 uC for 5 min before centrifugation at 16,100g to remove the precipitate.
All solvents were of HPLC-MS Grade purity purchased from Sigma-Aldrich (Gillingham, UK). HPLC grade formic acid was purchased from Fisher Scientific (Loughborough, UK). Mass spectrometer calibration solution and chromatography columns were purchased from Thermo-Fisher Scientific (Hemel Hempstead, UK).
All UHPLC-MS work was carried out on a Thermo-Finnigan Orbitrap-LTQ XL hybrid mass spectrometer operated in negative ionization mode coupled to a Thermo Accela autosampler (Fisher Scientific, Bremen, Germany). Chromatographic separations were adapted from work carried out by Fu and co-workers 34 and performed on a Thermo Hypersil Gold 2.1 mm C 18 column at a solvent flowrate of 400 ml min 21 . For initial profiling tests the column was eluted with 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B). The solvent composition during gradient elution was initiated with 5% (B) for 5 min and subsequently ramped to 95% (B) over 15 min, followed by a 5 min isocratic elution at 95% (B) before a return to 95% (A) held for further 5 min for column equilibration. All samples were maintained 4 uC within the autosampler refrigerator while the column was maintained at 50 uC within the autosampler oven. Mass calibration was carried out in accordance with the manufacturer's guidelines using RESEARCH LETTER caffeine (20 mg ml 21 ), the tetrapeptide MRFA (1 mg ml 21 ) and Ultramark 1621 (0.001%) in an aqueous solution of acetonitrile (50%), methanol (25%) and acetic acid (1%). Acquisition settings for initial profiling were carried out at 60,000 resolution in centroid and ran at 1 m-scan per 400 ms in the 100-1,000 m/z range with source gasses set at sheath gas 5 40 arbitrary units, aux gas 5 5 arbitrary units, sweep gas 5 5 arbitrary units. The ESI source voltage was set to 4.2 V, and capillary ion transfer tube temperature set at 275 uC.
Mass fragmentation analysis was carried out with the same column chemistry, source settings and flow rate but with an isocratic solvent elution of 55% (A)/45% (B), an optimum composition determined for eluting the analyte of interest, based on the initial elution profile described above. Mass spectrometry source, samples storage/column was kept under identical conditions. Collision induced dissociation (CID) settings were set up to trap ions 523 m/z with an isolation width of 1.0 m/z, normalized collision energy of 35, activation Q of 0.250 and activation time of 30 ms. DFT calculations. Density function theory (DFT) models were optimized in the gas phase using the B3LYP/6-31111G(d,p) or BH&H/6-31111G(d,p) level of theory implemented in Gaussian 09 (ref. 35) . Models are shown in Extended Data Fig. 7 and structural alignments to the crystal coordinates were performed using Swiss-PdbViewer version 4.1 (ref. 36) . Harmonic vibrational frequencies calculated using normal mode analysis were used to confirm that optimized geometries were always in local or global minima, and to calculate relative free energies. Data reporting. No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment.
Extended Data Figure 4 | EPR spectroscopy confirms Mn 21 binding. Left panel shows X-band continuous wave frozen solution EPR spectra of (A) Fdc1 UbiX and (B) Mn(H 2 O) 6 21 showing the characteristic six line pattern arising from the m s 5 6 1/2 spin manifold of the S 5 5/2 Mn 21 ion. The six line pattern reflects hyperfine coupling to the I 5 5/2 55 Mn nucleus and is sensitive to the environment of the ion, thus the differences between A and B indicate binding of Mn 21 to the enzyme. Experimental conditions: microwave power 0.5 mW, modulation amplitude 7 G, temperature 20 K. The right panel shows X-band continuous wave frozen solution EPR spectra of (A) Fdc1 UbiX reduced using sodium cyanoborohydride (NaBH 3 CN) and subsequently exposed to air and (B) wild-type UbiX 1 DMAP reduced with dithionite and reoxidised with oxygen. Experimental conditions: microwave power 10 mW, modulation amplitude 1.5 G, temperature 20 K. Reduction using NaBH 3 CN of the modified cofactor formed in Fdc1 UbiX (prFMN iminium ) gives rise to a radical on air oxidation with the same g value (g av ) and line width as that formed on the modified flavin (prFMN) in UbiX. However, the lack of the distinctive fine structure in A that is normally observed for the UbiX radical B, suggests heterogeneity in the Fdc1 UbiX radical or possibly a magnetic interaction with the nearby Mn 21 ion in Fdc1.
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Extended Data Figure 5 | Mass spectrometery of the Fdc1 UbiX cofactor. a, (i) Structural elucidation of the Fdc1 UbiX cofactor. Full scan total ion current (TIC) created under a gradient elution using H 2 O/acetonitrile both containing 0.1% formic acid indicating a major peak apex at 9.53 min with a 52/48 solvent composition. Also shown is the proposed structure of 523 m/z. Mass spectrum taken at major peak apex in (ii) (9.53 min) indicating an associated full-scan molecular ion peak with m/z 5 523.1589 (M 1 5 C 22 H 28 N 4 O 9 P) at a resolution of 58,501 with a mass accuracy of 0.06 p.p.m. Also eluting alongside the target molecule are two isotopic variants containing 13 C and 13 C 2 . The 13 C peak is displaying a relative abundance of 22 to the 523 m/z peak that is in line with the number of carbon atoms contained within the structure. Fragmentation of the 523.16 m/z molecular ion peak (iii) in an automated data dependent manner using helium based-chemical induced dissociation (CID level 35) generated a spectral tree that indicates the removal of the phosphate head group at the MS 2 level generating 425.18 m/z. Subsequent MS 3 level activation (CID 35) on 425.18 m/z partially (A) or completely (B) removing the tail group from the newly formed four-ring system generating 335.13 m/z or 309.09 m/z, respectively. The presence of a hydrolysed species with 541 m/z is also reported (iv). b, Native mass spectra of Fdc1 (top) and Fdc1 UbiX (bottom). Fdc1 presents in charge states 191 to 231, while Fdc1 UbiX presents in charge states 191 to 221. Right-hand spectrum; an enlarged view of the 211 charge state. The predicted masses are shown by blue dashed lines. The spectrum of Fdc1 UbiX shows that approximately two-thirds of the ions have two non-covalently bound cofactors, approximately one-third have one non-covalently bound cofactor and there is a small amount with no cofactor bound. Fdc1 contains no cofactor. The measured mass of the Fdc1 dimer is 112,265 Da (predicted mass from sequence is 112,270 Da). The measured mass for the apo form of Fdc1 UbiX is 112 345 Da, slightly higher than for Fdc1 which is attributed to an increased retention of salt. The mass difference of 180 Da corresponds to the mass of two potassium adducts. For the Fdc1 UbiX species with one bound cofactor, the measured mass (112,968 Da) is 178 Da higher than predicted. The predicted mass corresponds to the left hand side of the peak, which is the protein plus cofactor with no extra salt retained. The extra mass could be attributed to 2 Mn 21 ions and 2 K 1 ions. The Fdc1 UbiX bound to two cofactors has a measured mass of 113,583 Da, which is 268 Da larger than expected. Again, however, the predicted mass corresponds to the left-hand side of the peak. These spectra indicate that the protein dimer carries either 1 or 2 cofactors of 525 Da, along with a variety of other salt adducts. The extent of adductation is higher for Fdc1 UbiX and increases with bound cofactors, indicating that the addition of the cofactor recruits counter ions.
G2015 Macmillan Publishers Limited. All rights reserved Extended Data Figure 6 | A proposed mechanism for cofactor maturation in Fdc1 Ubix through oxidation. We propose the prFMN reduced cofactor produced by UbiX is bound by apo-Fdc1 and oxidized in a stepwise manner. Although the initial radical species resembles that observed during nonphysiological oxidation of the prFMN reduced -UbiX product complex 10 , we propose that in the Fdc1 enzyme proton abstraction from the prFMN radical C19 leads to a distinct radical species. The latter can either be oxidized further to the corresponding prFMN iminium or, via a radical based isomerization process, to form the central seven-membered ring ultimately leading to prFMN ketimine .
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Extended Data Figure 7 | DFT models of the proposed prFMN iminium and prFMN ketimine isomers and their substrate adducts. a, Chemical structures of the prFMN iminium and prFMN ketimine models. DFT models (pink carbons) are overlaid with crystal coordinates (green carbons) of prFMN iminium (b) and the two butterfly bent conformations of prFMN ketimine (c, d). c, d, The substratefree (bent 'up') prFMN ketimine is shown in c and the more planar substratebound (bent 'down') in d. For comparison of the extent of the butterfly bending of prFMN ketimine , the two DFT models in c and d are aligned over the four-ring nitrogen atoms and overlaid in e. f, Chemical structures of the proposed initial prFMN iminium and prFMN ketimine substrate adducts with the cinnamic acid substrate highlighted in red. The DFT-optimized structures of these species are overlaid in g with the prFMN iminium species shown with pink carbons and the prFMN ketimine species with teal carbons. Three projections of overlaid DFT models of the prFMN iminium species with substrate bound (pink carbons; reproduced from g), after substrate decarboxylation (teal carbons; substrate double bond is cis) and upon protonation of the substrate b-carbon (green carbons) are shown in h). Note that the substrate carboxylate was artificially protonated in these models to maintain charge neutrality. Models were geometry optimized in the gas phase using either the B3LYP/6-31111 G(d,p) (panels a-e) or BH&H/6-31111 G(d,p) (panels f-h) level of theory. BH&H was chosen over B3LYP for the substrate adducts as BH&H has been shown to better describe p-stacking interactions, which are likely to occur between the modified isoalloxazine and substrate phenyl moieties 37 . Harmonic vibrational frequencies calculated using normal mode analysis were used to confirm that optimized geometries of all species were in local or global minima. Absolute energies and relative free energies of the substrate-free species, determined from the normal mode calculations, are given in the table, top right. Cartesian coordinates of the optimized structures are given in the Supplementary Information.
